Navigation Links
GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
Date:9/15/2009

icant growth potential. Prime BioResearch currently has a proprietary portfolio of six worldwide patents in Obesity and Diabetes-II worth $2.9 billion, if successfully brought through development, clinical trials, and to market (Source: PriceWaterhouseCoopers). The Company's mission is to make safe and effective drugs available to the public, quickly and at affordable levels.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec. Visit GENova online at: www.genovabio.com

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova gains access to Big Pharma
2. GENova appoints Dr. Wang Chong to Scientific Advisory Board
3. GENova appoints Dr. Philip Gould to Scientific Advisory Board
4. GENova issues clarifying press release
5. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
6. GENova files patent for new breast cancer treatment
7. GENova appoints Director of Asian business development
8. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
9. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
10. Genova files patent for new prostate cancer treatment
11. GENova names Dr. John Savin as Vice President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... According to the ... marijuana is legal, and are exposed to advertisements, for medicinal use are more likely ... in settings where the use of marijuana is considered beneficial are more apt to ...
(Date:7/29/2015)... ... 2015 , ... The report “Atherosclerosis - Pipeline Review, H1 ... slow, progressive disease that may start in childhood. The report strengthens R&D pipelines ... report on Atherosclerosis Pipeline with 78 market data tables and 15 figures, spread ...
(Date:7/29/2015)... LAUREL, NJ (PRWEB) , ... July 29, 2015 ... ... Certification’s (the Commission) CCM® credential for a five-year period, expiring November 30, 2019, ... its CCM credential by submitting an application demonstrating the program’s compliance with the ...
(Date:7/29/2015)... ... 29, 2015 , ... CrossFit 269, offering a nationally franchised ... Strength & Conditioning. , The name change coincides with the release of its ... center over the past three years,” according to Jack Kelly, the center’s owner ...
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage companies. ... a group of experienced investors, has tapped into an investor community passionate about Sofia’s ... part of the fund. The Sofia Fund II is now closed to investors, ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2
... that there is an increase in the number of people ... insect stings. , Anaphylaxis is found to be ... Statistics show that about 3,000 people suffer from allergic reactions ... is a shortage of data about allergic reactions due to ...
... the medical services has been blamed for failing to properly ... James Tierney ruled that the system failed in case of ... each case, had these signs and symptoms which were presenting ... not be properly understood been itself identified, there is a ...
... a protein that they say could be responsible for triggering ... more accurate tests for such allergies.// ,Researchers led by ... York, showed for the first time that CD23, a protein ... receptor for IgE, a protein associated with allergic reactions. ...
... influenza virus while plans are in place to vaccinate the ... form of bird flu. Dr. Thonton said that other bird ... avian influenza virus. ,The highly pathogenic bird flu ... the year 2003.It remains difficult for humans to contact the ...
... Government's practice nurse subsidy should be offered to all general ... ,"Family doctors want to look after their ... to provide the best possible health care at a time ... ,"Integrating nurses into general practice makes sense to them and ...
... healthcare, the Jharkhand government has set up a trust that ... partly funded// by private investors in the state. ... Chief Minister Arjun Munda who has roped in major investors ... a health card for poor families. ,"Private ...
Cached Medicine News:Health News:Protein Behind Food Allergies Identified 2Health News:Call For Better Funding Of Doctor-Nurse Teams 2
(Date:7/29/2015)... , July 29, 2015  Depomed, Inc. (NASDAQ: ... announced that its Board of Directors, after careful ... financial and legal advisors, has unanimously rejected the ... from Horizon Pharma plc (NASDAQ: HZNP ) ... of Depomed in an all-stock transaction (the "July ...
(Date:7/29/2015)... , July 29, 2015 Immune Pharmaceuticals Inc. ... secured financings of up to $21.5 million through two ... Inc. (NYSE: HTGC ) ("Hercules"), for a term loan ... mutual fund Discover Growth Fund ("Discover"), for the sale ... Preferred Stock ("Preferred Stock") for up to $12 million ...
(Date:7/29/2015)... DIEGO , July 29, 2015 ... July 23, called the Alvarado Spine & Joint ... surgery and rehabilitation, focusing on spinal surgery and ... of patient care takes a patient experience-focused approach. ... clothing they feel comfortable in, rather than patient ...
Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 17.0 mm and length 21 mm....
Medicine Products: